[1. Griffiths CEM, Barker JNWN. Psoriasis. In: BurnsT, Breathnach S, Cox N, Griffiths C. Rook’s textbook of dermatology. 8th ed. Chapter 20.London: Wiley-Blackwell; 2010. p. 1-60.10.1002/9781444317633.ch20]Search in Google Scholar
[2. White SW. Palmoplantar pustular psoriasis provoked by lithium therapy. J Am Acade Dermatol 1982;7:660-2.10.1016/S0190-9622(82)70147-1]Search in Google Scholar
[3. Cohen JD, Bournerias I, Buffard V, Paufler A, Chevalier X, Bagot M, et al. Psoriasis induced by tumor necrosis factor - alpha antagonist therapy: a case series. J Rheumatol 2007;34:380-5.]Search in Google Scholar
[4. Saez-Rodriguez M, Noda-Cabrera A, Alvarez-Tejera S, Guimera-Martin-Neda F, Dorta-Alom S, Escoda-Garcia M, et al. The role of psychological factors in palmoplantar pustulosis. J Eur Dermatol Venereol 2002;16:325-7.10.1046/j.1468-3083.2002.00538.x]Search in Google Scholar
[5. Rosen K, Lindstedt G, Mobacken H, Nystrom E. Thyroid function in patients with pustulosis palmoplantaris. J Am Acad Dermatol 1998;19:1009-16.10.1016/S0190-9622(88)70265-0]Search in Google Scholar
[6. Gimenez-Garcia R, Sanchez-Ramon S, Cuellar-Olmedo LA. Palmoplantar pustulosis: a clinico-epidemiological study. The relationship between tobacco use and thyreoid function. J Eur Dermatol Venereol 2003;17:276-9.10.1046/j.1468-3083.2003.00510.x]Search in Google Scholar
[7. Hagforsen E. The cutaneous non neuronal cholinergic system and smoking related dermatoses: studies of the psoriasis variant palmoplantar pustulosis. Life Sci 2007;80: 2227-34.10.1016/j.lfs.2007.01.045]Search in Google Scholar
[8. Pettey AA, Balkrishnan R, Rapp SR, Fleischner AB, Feldman SR. Patient with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implication for clinical practice. J Am Acad Dermatol 2003;49; 271-5.10.1067/S0190-9622(03)01479-8]Search in Google Scholar
[9. Asumalahti K, Ahmeen M, Evans JC, Burden D, Griffiths CEM, Barker JNWN, et al. Analysis of PSORS1 single nucleatide polymorphismus in guttate psoriasis and palmoplantar pustular psoriasis. Br J Dermatol 2002;147:1053.]Search in Google Scholar
[10. Enfors W, Molin L. Pustulosis palmaris et plantaris: a folow-up study of a ten-year material. Acta Derm Venereol 1971;51:289-94.]Search in Google Scholar
[11. Brunasso AMG, Masone C. Can we really separate palmoplantar pustulosis from psoriasis? J Eur Dermatol Venereol 2010;24:619-21.]Search in Google Scholar
[12. Aydin O, Engin B, Oguz O, Ilvan S, Demirkesen C. Nonpustular palmoplantar psoriasis: is histologic differentiation from eczematous dermatitis possible? J Cutan Pathol 2008;35:169-73.]Search in Google Scholar
[13. Yamamoto T. Extra-palmoplantar lesions associated with palmoplantar pustulosis. J Eur Dermatol Venereol 2009;23:1227-32.10.1111/j.1468-3083.2009.03296.x19453807]Search in Google Scholar
[14. Chalmers R, Hollis S, Leonardi-Bee J, Griffiths CEM, Marsland A. Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev 2009;(l):1-49.]Search in Google Scholar
[15. Lassus A, Geiger JM. Actitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial. Br J Dermatol 1988;119:755-9.10.1111/j.1365-2133.1988.tb03499.x2974306]Search in Google Scholar
[16. Murray D, Corbett MF, Warin AP. A controlled trial of photochemotherapy for persistent palmoplantar pustulosis. Br J Dermatol 1980;102:659-63.10.1111/j.1365-2133.1980.tb06565.x7000136]Search in Google Scholar
[17. Rosen K, Mabachen H, Swanbeck G. PUVA, etretinate and PUVA - etretinate therapy for pustulosis palmoplantaris. Arch Dermatol 1987;123:885-9.10.1001/archderm.1987.016603100530133300565]Search in Google Scholar
[18. Layton AM, Sheehan-Dare R, Cunliffe WJ. A doubleblind placebo-controlled trial of topical PUVA in persistent palmoplantar pustulosis. Br J Dermatol 1991;124:581-4.10.1111/j.1365-2133.1991.tb04955.x2064943]Search in Google Scholar
[19. Matsunami E, Takashima A, Mizuno N, Jinno T, Ito H. Topical PUVA, etretinate and combined PUVA and etretinate for palmoplantar pustulosis: comparation of therapeutic efficacy and the influences of tonsillar and dental focal infections. J Dermatol 1990;17: 92-6.10.1111/j.1346-8138.1990.tb03713.x2184179]Search in Google Scholar
[20. Lassus A, Lauharanta J, Eskelinen A. The effect of etretinate compared with different regimens of PUVA in the treatment of persistent palmoplantar pustulosis. Br J Dermatol 1985;112:455-9.10.1111/j.1365-2133.1985.tb02320.x3888246]Search in Google Scholar
[21. Lawrence CM, Marks J, Parker S, Shuster S. A comparison of PUVA - etretinate and PUVA- placebo for palmoplantar pustular psoriasis. Br J Dermatol 1984;110:221-6.10.1111/j.1365-2133.1984.tb07471.x6696838]Search in Google Scholar
[22. Bhushan M, Burden AD, McElhone K, James R, Vanhorette FP, Griffiths CEM. Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo controlled study. Br J Dermatol 2001;145:546-53.10.1046/j.1365-2133.2001.04411.x11703279]Search in Google Scholar
[23. Erkko P, Granlund H, Remitz A, Rosen K, Mobacken H, Lindeloef B, et al. Double-blind placebo-controlled trial of longterm low-dose cyclosporin in the treatment of palmoplantar pustulosis. Br J Dermatol 1998;166:220-3.]Search in Google Scholar
[24. Reitamo S, Erkko P, Remitz A, Lauerma Al, Montonen O, Harjula K. Cyclosporin in the treatment of palmoplantar pustulosis: a randomized, double-blind, placebo-controlled study. Arch Dermatol 1993;129:1273-9.10.1001/archderm.1993.01680310043006]Search in Google Scholar
[25. Thomsen K, Osterbye P. Pustulosis palmaris et plantaris. Br J Dermatol 1973;89: 293-6.10.1111/j.1365-2133.1973.tb02977.x4582718]Search in Google Scholar
[26. Hattel T, Sondergaard J. Pustulosis palmaris et plantaris treated with hydroxyurea. Acta Derm Venereol 1974;54:152-4.]Search in Google Scholar
[27. Thestrup-Pedersen K, Reymann F. Treatment of pustulosis palmaris et plantaris with colchicine. Acta Derm Venereol 1984;64:76-8.]Search in Google Scholar
[28. Mann RJ. Failure of colhicine for palmoplantar pustulosis. Br J Dermatol 1982;106; 373.10.1111/j.1365-2133.1982.tb01740.x7039659]Search in Google Scholar
[29. Adisen E, Tekin O, Gulekon A, MA Gurer. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J Eur Dermatol Venereol 2009;23: 814-9.10.1111/j.1468-3083.2009.03197.x19470063]Search in Google Scholar
[30. Lindeloef B, Beitner H. The effect of grenz ray therapy on pustulosis palmoplantaris. Acta Derm Venereol 1990;70:529-31.]Search in Google Scholar
[31. Mrowietz U. Pustular eruptions of palmes and soles. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 7th ed. New York: Mc Grow Hill Medical; 2008. p. 215-8.]Search in Google Scholar
[32. Kragballe K, Larsen FG. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis. Acta Derm Venereol 1991;71:540-2.]Search in Google Scholar
[33. Breathnach SM, Smith CH, Chalmers RJ, Hay RJ. Systemic therapy. In: Burns T, Breathnach S, Cox N, Griffiths C. Rook’s textbook of dermatology. 8th ed. Chapter 74. London: Wiley- Blackwell; 2010. p. 1-53.10.1002/9781444317633.ch74]Search in Google Scholar